Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma

Annals of Oncology

Volumn 20, Issue 4, 2009, Pages 780-787

  Kim, H R ^a   Rha, S Y ^a   Cheon, S H ^a,b   Roh, J K ^a   Park, Y N ^a   Yoo, N C ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Chemotherapy; Primary hepatic angiosarcoma; Treatment outcomes

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; DOXORUBICIN; FLUOROURACIL; IFOSFAMIDE; PACLITAXEL;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ANGIOSARCOMA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CANCER; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ANTINEOPLASTIC AGENTS; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 63549151134     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn702     Document Type: Article

References (48)

1. Mani H, Van Thiel DH. Mesenchymal tumors of the liver. Clin Liver Dis 2001; 5: 219-257, viii.
2. Molina E, Hernandez A. Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci 2003; 48: 677-682.
3. Bolt HM. Vinyl chloride - a classical industrial toxicant of new interest. Crit Rev Toxicol 2005; 35: 307-323.
4. Lee FI, Smith PM, Bennett B, Williams DM. Occupationally related angiosarcoma of the liver in the United Kingdom 1972-1994. Gut 1996; 39: 312-318.
5. Thomas LB, Popper H, Berk PD et al. Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to Angiosarcomas. N Engl J Med 1975; 292: 17-22.
6. Lyburn ID, Torreggiani WC, Harris AC et al. Hepatic epithelioid hemangioendothelioma: Sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol 2003; 180: 1359-1364.
7. Tateishi U, Hasegawa T, Muramatsu Y, Moriyama N. Hepatic metastases of soft tissue angiosarcoma: CT and MR imaging findings. Abdom Imaging 2003; 28: 660-664.
8. Yu R, Zhang S, Hua J. Hepatic angiosarcoma: CT findings. Chin Med J (Engl) 2003; 116: 318-320.
9. Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical features of hepatic angiosarcoma: A report of four cases and a review of the English literature. Medicine (Baltimore) 1979; 58: 48-64.
10. Cady B, Bonneval M, Fender HR Jr. Elective hepatic resection. Am J Surg 1979; 137: 514-521.
11. Rui J, Wang S, Chen S. Hepatic trisegmentectomy for 29 patients with huge neoplasms of liver. Zhonghua Wai Ke Za Zhi 2001; 39: 759-763.
12. Weitz J, Klimstra DS, Cymes K et al. Management of primary liver sarcomas. Cancer 2007; 109: 1391-1396.
13. Kang H, Lee J, Kim M et al. A case of hepatic angiosarcoma presenting as submucosal tumor resulting from gastric invasion. Korean J Gastrointest Endosc 2005; 31: 257-262.
14. Lee W, Kim J, Kim Y et al. A case of primary angiosarcoma of the liver. Korean J Hepatol 1999; 5: 246-252.
15. Lee Y, Hwang J, Park K et al. A case of primary hepatic angiosarcoma: report of a case and review of previous Korean cases. Korean J Med 2004; 66: 224-229.
16. Park B, Park W, Kim B et al. Angiosarcoma of the liver: A case report. J Korean Radiol Soc 1997; 36: 1033-1036.
17. Park S, Chon C, Shin H et al. A case of primary hepatic angiosarcoma. Korean J Med 1993; 45: 818-822.
18. Abraham JA, Hornicek FJ, Kaufman AM et al. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 2007; 14: 1953-1967.
19. Mathew P, Vakar-Lopez F, Troncoso P. Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin. Lancet Oncol 2006; 7: 92-93.
20. Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 2005; 104: 361-366.
21. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
22. Almogy G, Lieberman S, Gips M et al. Clinical outcomes of surgical resections for primary liver sarcoma in adults: Results from a single centre. Eur J Surg Oncol 2004; 30: 421-427.
23. Arima-Iwasa S, Chijiiwa K, Makino I et al. A case of hepatic angiosarcoma surviving for more than 16 months after hepatic resection. Hepatogastroenterology 2007; 54: 533-535.
24. Timaran CH, Grandas OH, Bell JL. Hepatic angiosarcoma: Long-term survival after complete surgical removal. Am Surg 2000; 66: 1153-1157.
25. Ozden I, Bilge O, Erkan M et al. Five years and 4 months of recurrence-free survival in hepatic angiosarcoma. J Hepatobiliary Pancreat Surg 2003; 10: 250-252.
26. Dannaher CL, Tamburro CH, Yam LT. Chemotherapy of vinyl chloride-associated hepatic angiosarcoma. Cancer 1981; 47: 466-469.
27. Ikeda K, Maehara M, Ohmura N et al. Spontaneous rupture of a necrotic hepatic angiosarcoma: Findings on dual-phase computed tomography and angiography. Radiat Med 2006; 24: 369-372.
28. Fayette J, Martin E, Piperno-Neumann S et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: A retrospective study of 161 cases. Ann Oncol 2007; 18: 2030-2036.
29. Penel N, Bui BN, Bay JO et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: The ANGIOTAX study. J Clin Oncol 2008 Sep 22. [Epub ahead of print].
30. Fata F, O'Reilly E, Ilson D et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999; 86: 2034-2037.
31. Mano MS, Fraser G, Kerr J et al. Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy. Breast 2006; 15: 117-118.
32. Pestoni C, Paredes-Suarez C, Peteiro C, Toribio J. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with paclitaxel. J Eur Acad Dermatol Venereol 2005; 19: 357-359.
33. Tomasello L, Gardin G, Boccardo F. Secondary breast angiosarcoma: Lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report. Anticancer Res 2006; 26: 4775-4777.
34. Yamada M, Hatta N, Mizuno M et al. Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head. Br J Dermatol 2005; 152: 811-812.
35. Budd GT. Management of angiosarcoma. Curr Oncol Rep 2002; 4: 515-519.
36. D'Adamo DR, Anderson SE, Albritton K et al. Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas. J Clin Oncol 2005; 23: 7135-7142.
37. D'Adamo DR, Keohan M, Schuetze S et al. Clinical results of a phase II study of sorafenib in patients (pts) with non-GIST sarcomas (CTEP study #7060). J Clin Oncol 2007; 25: 18S (Abstr 10001).
38. Penel N, Lansiaux A, Adenis A. Angiosarcomas and taxanes. Curr Treat Options Oncol 2007; 8: 428-434.
39. Nagano T, Yamada Y, Ikeda T et al. Docetaxel: A therapeutic option in the treatment of cutaneous angiosarcoma: Report of 9 patients. Cancer 2007; 110: 648-651.
40. Ho S, Lau WY, Leung TW, Johnson PJ. Internal radiation therapy for patients with primary or metastatic hepatic cancer: A review. Cancer 1998; 83: 1894-1907.
41. Jakobs TF, Hoffmann RT, Poepperl G et al. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 2007; 17: 1320-1330.
42. Kennedy A, Nag S, Salem R et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007; 68: 13-23.
43. Neff R, Abdel-Misih R, Khatri J et al. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors. Cancer Invest 2008; 26: 173-177.
44. King J, Quinn R, Glenn DM et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008; 113: 921-929.
45. Gulec SA, Fong Y. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 2007; 142: 675-682.
46. Sato KT, Lewandowski RJ, Mulcahy MF et al. Unresectable chemorefractory liver metastases: Radioembolization with 90Y microspheres - safety, efficacy, and survival. Radiology 2008; 247: 507-515.
47. Tordjman R, Eugene C, Clouet O et al. [Hepatosplenic angiosarcoma complicated by hemoperitoneum and disseminated intravascular coagulation. Treatment by arterial embolization and chemotherapy]. Gastroenterol Clin Biol 1995; 19: 625-628.
48. Mahony B, Jeffrey RB, Federle MP. Spontaneous rupture of hepatic and splenic angiosarcoma demonstrated by CT. AJR Am J Roentgenol 1982; 138: 965-966.